Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05930938
Title Study Comparing RT With Cetuximab + Xevinapant to RT With Cetuximab-placebo in Patients With Head and Neck Cancer (XXL_2022-01)
Acronym XXL_2022-01
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Groupe Oncologie Radiotherapie Tete et Cou
Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.